AlphaCentric Advisors LLC's Q2 2023 13F: 77 new positions, 55 exits

Form 13F-HR for the quarter ended Jun 30, 2023 · filed Aug 8, 2023 · 231 reported positions · accession 0001162044-23-000820

What changed this quarter

AlphaCentric Advisors LLC's changes in reported equity positions, Q2 2023
Activity Security Weight before Weight now Change Shares Shares %
Increased JAZZ PHARMACEUTICALS PLC (JAZZ) 0.7% 2.8% +2.1 pts +33,750 sh +482%
Reduced ISHARES TR (SHY) 4.4% 1.2% −3.2 pts −50,199 sh −65%
Exited INVESCO QQQ TR (QQQ) 1.9% — −1.9 pts −8,749 sh −100%
Exited INVESCO EXCH TRADED FD TR II (QQQM) 1.9% — −1.9 pts −21,262 sh −100%
Exited INNOVIVA INC (INVA) 1.4% — −1.4 pts −184K sh −100%
New INVESCO EXCHANGE TRADED FD T (RPV) — 1.3% +1.3 pts +31,211 sh new
Increased COHERUS BIOSCIENCES INC (CHRS) 1.7% 2.2% +0.5 pts +558K sh +157%
New ISHARES TR (IWD) — 1.3% +1.3 pts +15,005 sh new
Increased AMYLYX PHARMACEUTICALS INC (AMLX) 0.2% 1.3% +1.1 pts +101K sh +1340%
New ISHARES TR (MBB) — 1.1% +1.1 pts +21,955 sh new
Exited BIO RAD LABS INC (BIO) 1.1% — −1.1 pts −3,400 sh −100%
Increased ADAPTHEALTH CORP (AHCO) 1.0% 1.9% +0.9 pts +166K sh +142%
New EMBECTA CORP (EMBC) — 1.1% +1.1 pts +93,500 sh new
Increased NEUROCRINE BIOSCIENCES INC (NBIX) 1.1% 1.9% +0.8 pts +21,000 sh +135%
New PHATHOM PHARMACEUTICALS INC (PHAT) — 1.0% +1.0 pts +130K sh new
Increased HARMONY BIOSCIENCES HLDGS IN (HRMY) 1.5% 2.3% +0.8 pts +50,500 sh +75%
New IRONWOOD PHARMACEUTICALS INC (IRWD) — 0.9% +0.9 pts +158K sh new
New AMICUS THERAPEUTICS INC (FOLD) — 0.9% +0.9 pts +133K sh new
New UROGEN PHARMA LTD (URGN) — 0.9% +0.9 pts +153K sh new
Increased WALGREENS BOOTS ALLIANCE INC (WBA) 0.7% 1.3% +0.6 pts +52,000 sh +186%
Exited AMRYT PHARMA PLC (AMYT) 0.8% — −0.8 pts −81,000 sh −100%
New DAY ONE BIOPHARMACEUTICALS I (DAWN) — 0.7% +0.7 pts +110K sh new
Exited NOVAVAX INC (NVAX) 0.7% — −0.7 pts −150K sh −100%
Exited DOCGO INC (DCGO) 0.7% — −0.7 pts −120K sh −100%
Reduced 2SEVENTY BIO INC (TSVT) 2.1% 1.0% −1.1 pts −123K sh −40%
New KALVISTA PHARMACEUTICALS INC (KALV) — 0.7% +0.7 pts +135K sh new
Increased UNITED THERAPEUTICS CORP DEL (UTHR) 0.5% 1.1% +0.6 pts +5,500 sh +157%
New VERASTEM INC (VSTM) — 0.6% +0.6 pts +150K sh new
Exited INMODE LTD (INMD) 0.6% — −0.6 pts −27,000 sh −100%
New SYMBOTIC INC (SYM) — 0.6% +0.6 pts +25,000 sh new
Reduced GSK PLC (GSK) 2.0% 1.0% −1.0 pts −30,000 sh −38%
Increased BIOCRYST PHARMACEUTICALS INC (BCRX) 2.4% 2.2% −0.2 pts +151K sh +36%
Increased KARYOPHARM THERAPEUTICS INC (KPTI) 0.6% 0.8% +0.2 pts +570K sh +238%
Increased RWT HLDGS INC (RWT 5.75 10/01/25) 0.7% 1.1% +0.4 pts +1.16M sh +103%
Exited TARO PHARMACEUTICAL INDS LTD (TARO) 0.5% — −0.5 pts −32,500 sh −100%
Increased ARCUTIS BIOTHERAPEUTICS INC (ARQT) 1.4% 1.5% +0.1 pts +103K sh +54%
Increased BIOMARIN PHARMACEUTICAL INC (BMRN) 0.4% 0.8% +0.4 pts +11,000 sh +200%
Increased MGIC INVT CORP WIS (MTG) 0.5% 1.0% +0.5 pts +60,000 sh +111%
Exited BIOXCEL THERAPEUTICS INC (BTAI) 0.5% — −0.5 pts −40,000 sh −100%
New SOUNDHOUND AI INC (SOUN) — 0.5% +0.5 pts +200K sh new
New ARGENX SE (ARGX) — 0.5% +0.5 pts +2,250 sh new
New CRINETICS PHARMACEUTICALS IN (CRNX) — 0.5% +0.5 pts +47,000 sh new
Increased PACIRA BIOSCIENCES INC (PCRX) 1.0% 1.3% +0.2 pts +20,500 sh +57%
Increased ELANCO ANIMAL HEALTH INC (ELAN) 1.4% 1.6% +0.3 pts +80,000 sh +37%
Increased TWO HARBORS INVENTMENT CORPO (TWO 6.25 01/15/26) 0.8% 1.1% +0.3 pts +890K sh +68%
Reduced MR COOPER GROUP INC (COOP) 1.6% 1.2% −0.4 pts −15,500 sh −27%
Exited SOMALOGIC INC (SLGC) 0.4% — −0.4 pts −240K sh −100%
New FISCALNOTE HOLDINGS INC (NOTE) — 0.4% +0.4 pts +200K sh new
Exited SANOFI (SNY) 0.4% — −0.4 pts −10,000 sh −100%
Reduced CENTENE CORP DEL (CNC) 2.2% 1.5% −0.7 pts −10,000 sh −20%

The 50 largest of 251 changes, by size of the trade. Full holdings for this quarter.

Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled

Top 10 positions — 21.6% of the equity book

Changes in the top 10 this quarter: JAZZ entered · HRMY entered · CHRS entered · NBIX entered · AHCO entered · EFC entered · ELAN entered · SHY left · CNC left · TSVT left · GSK left · QQQ left · QQQM left · HZNP left

# Security Weight before Weight now
1 JAZZ PHARMACEUTICALS PLC (JAZZ) 0.7% 2.8% Entered the top 10
2 NEW RESIDENTIAL INVT CORP (RITM) 2.7% 2.6%
3 HARMONY BIOSCIENCES HLDGS IN (HRMY) 1.5% 2.3% Entered the top 10
4 GALAPAGOS NV (LKFT) 2.5% 2.2%
5 BIOCRYST PHARMACEUTICALS INC (BCRX) 2.4% 2.2%
6 COHERUS BIOSCIENCES INC (CHRS) 1.7% 2.2% Entered the top 10
7 NEUROCRINE BIOSCIENCES INC (NBIX) 1.1% 1.9% Entered the top 10
8 ADAPTHEALTH CORP (AHCO) 1.0% 1.9% Entered the top 10
9 ELLINGTON FINANCIAL INC (EFC) 1.7% 1.8% Entered the top 10
10 ELANCO ANIMAL HEALTH INC (ELAN) 1.4% 1.6% Entered the top 10
— ISHARES TR (SHY) 4.4% 1.2% Left the top 10
— CENTENE CORP DEL (CNC) 2.2% 1.5% Left the top 10
— 2SEVENTY BIO INC (TSVT) 2.1% 1.0% Left the top 10
— GSK PLC (GSK) 2.0% 1.0% Left the top 10
— INVESCO QQQ TR (QQQ) 1.9% 0.0% Left the top 10
— INVESCO EXCH TRADED FD TR II (QQQM) 1.9% 0.0% Left the top 10
— HORIZON THERAPEUTICS PUB L (HZNP) 1.9% 1.5% Left the top 10

Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).

Option positions (puts and calls)

Reported separately from the positions above. The value a 13F reports for an option is that of the underlying shares, not the option itself.

Activity Security Type Shares before Shares now Reported value
New UNITED RENTALS INC (URI) Call 0 342 $152K